Research focus: Leukemia and leukemia biology and radiation epidemiology.
An Examination of IRF8 as a Biomarker of aging, Malignant Transformation, and Prognosis
Integrating Diagnostics with Therapeutic Strategies in Chronic Myeloid Leukemia
Proteomic Signatures Associatedd with Complete Response and Complete Continuous Response at One Year Following Cytarabine-based Induction Chemotherapy in Younger Adult Patients (18-60 Years of age) with a Newly Diagnosed Non-M3 AML
Cancer Mortality among Military Participants at US Nuclear Weapons Tests
Functional Methods for Radiation Exposure and Biomarker Data
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.